Previous Article | Next Article ![]()
Journal of Clinical Microbiology, Mar 1997, 667-672, Vol 35, No. 3
G Morace, M Sanguinetti, B Posteraro, G Lo Cascio and G Fadda
A single primer pair amplifying a cytochrome P-450 lanosterol-14 alpha-
demethylase (L1A1) gene fragment that encodes a highly conserved region was
used to detect yeast DNA in clinical specimens. Positive PCR products were
obtained from genomic DNAs of Candida albicans, C. parapsilosis, C.
tropicalis, C. guilliermondii, C. krusei, C. (Torulopsis) glabrata, and C.
kefyr. No human, bacterial, or parasitic DNA was amplified. The sensitivity
was evaluated for C. albicans genomic DNA by using various DNA
concentrations (200 pg to 2 fg). The amplified DNAs of Candida species with
unknown P-450 L1A1 gene sequences were subcloned and sequenced.
Identification at the species level was achieved by digestion of the PCR
products with different restriction enzymes. A specific restriction enzyme
analysis pattern was determined for each species investigated.
Subsequently, we used PCR to detect specific yeast DNA directly with
clinical specimens such as blood and bronchoalveolar lavage specimens.
After appropriate treatment, the specimens were processed by PCR and the
results were compared with those obtained by traditional diagnostic
procedures such as cultures and serology. Although preliminary, the PCR
results seem to correlate well, at least for blood, with those of antigen
detection assays and traditional blood cultures, with a better and earlier
detection of candidemia.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Identification of various medically important Candida species in clinical specimens by PCR-restriction enzyme analysis
Istituto di Microbiologia, Universita Cattolica Sacro Cuore, Rome, Italy.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|